Scleritis with Devastating Consequences.

Originally received: April 24, 2016. Final revision: July 18, 2016. Accepted: July 20, 2016. Available online: September 2, 2016. Manuscript no. 2016-858. 1 Department of Ophthalmology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. 2 Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. 3 Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York, New York. Financial Disclosure(s): The author(s) have made the following disclosure(s): R.R.: Consultant e GLIA, LLC; Guardion Health Sciences; Mobius Therapeutics; Intelon Optics, Inc., Diopsys, Inc.; Gerson Lehrman Group; Sensimed, AG; Aeon Astron Europe, B.V.; Board membership e iSonic Medical; Xoma (U.S.) LLC; Expert testimony e Donahey, Defossez & Beausay; Tanoury, Nauts, McKinney & Barbarino, PLLC; Blume Forte Fried Zerres & Molinari; Lecturer e Santen Pharmaceutical Co., Ltd.; Royalties e Ocular Instruments, Inc.; Equity owner e The International Eye Wellness Institute, Inc. Author Contributions: Conception and design: Teekhasaenee, Suwan, Supakontanasan, Tulvatana, Ritch Analysis and interpretation: Teekhasaenee, Suwan, Supakontanasan, Tulvatana, Ritch Data collection: Teekhasaenee, Suwan, Supakontanasan, Tulvatana Obtained funding: none Overall responsibility: Teekhasaenee Abbreviations and Acronyms: DRS 1⁄4 double-ring sign; LI 1⁄4 laser iridotomy; PEX 1⁄4 pseudoexfoliation; POAG 1⁄4 primary open-angle glaucoma; TEX 1⁄4 true exfoliation syndrome; UBM 1⁄4 ultrasound biomicroscopy. Correspondence: Chaiwat Teekhasaenee, MD, Department of Ophthalmology, Ramathibodi Hospital, Rama 6, Bangkok 10400, Thailand. E-mail: chai1391@ gmail.com.